Kereos Inc.

This analysis of recent public and private device financings demonstrates that the device industry has rebounded from a dismal public market and is showing strength among both public and private inves

This analysis of recent public and private device financings demonstrates that the device industry has rebounded from a dismal public market and is showing strength among both public and private inves

Improved drug efficacy and safety through nanotechnology 161 First Street Cambridge, MA 02142 Phone: (617) 551-9600 Fax: (617) 494-1544 Web Site: www.tempopharmaceuticals.com Contact: Alan Crane, CEO

NCI's invigorated effort to expedite benchtop to bedside technology development has benefited companies, but the collaborations aren't always easy. By Wendy Diller National Institutes of Health (NI